Get started
Author

Jindan Kai

Observed name: Jin‐Dan Kai
ORCID: 0009-0005-0359-5702
Observed ORCID: 0009-0005-0359-5702
OpenAlex ID: A5083522427
lncRNA HOXB‐AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K‐AKT pathway
2020 · Wenyang Jiang, Jindan Kai, et al. · Journal of Cellular Physiology · 58
Recent progress on elucidating the molecular mechanism of plasmid-mediated colistin resistance and drug design
2019 · Jindan Kai, Sheng Wang · International Microbiology · 29
PDF
MYH9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis
2022 · Jin‐Dan Kai, Liang‐Hao Cheng, et al. · Cell Biology International · 28
A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non–Small Cell Lung Cancer
2022 · Ping Lu, Yifei Ma, et al. · Frontiers in Molecular Biosciences · 15
PDF
Prognostic Prediction Models Based on Clinicopathological Indices in Patients With Resectable Lung Cancer
2020 · Yanyan Liu, Xinying Li, et al. · Frontiers in Oncology · 9
PDF
Genetic and pharmacological inhibition of eIF4E effectively targets esophageal cancer cells and augments 5-FU’s efficacy
2018 · Jindan Kai, Yiqiao Wang, et al. · Journal of Thoracic Disease · 9
PDF
ASAP3 is a downstream target of HIF-1α and is critical for progression of lung adenocarcinoma
2019 · Pingping Zhang, Junwei Sun, et al. · OncoTargets and Therapy · 8
PDF
Post-radiotherapy maintenance treatment with fluticasone propionate and salmeterol for lung cancer patients with grade III radiation pneumonitis: A case report
2018 · Pingping Zhang, Hongxia Yan, et al. · Medicine · 5
Capivasertib reverses chemotherapy-induced esophageal cancer resistance via inhibiting Akt-associated Mcl-1 upregulation
2024 · Jindan Kai, Kai Kang, et al. · Heliyon · 4
Video-assisted thoracic surgery right sleeve lobectomy.
2014 · Fei Xiong, Sheng Wang, et al. · Europe PMC (PubMed Central) · 4
Abstract CT014: Perioperative adebrelimab (A) plus chemotherapy (chemo) in resectable stage II-III NSCLC: Phase 3 EFS interim analysis (IA) and molecular residual disease (MRD) analysis
2026 · Yi-Long Wu, Wen-Zhao Zhong, et al. · Cancer Research · 3
The low advanced lung cancer inflammation index to predict poor prognosis of patients with metastatic non-small cell lung cancer.
2021 · Ping Lu, Yifei Ma, et al. · Journal of Clinical Oncology · 2
Almonertinib as a neoadjuvant therapy for patients with a superior pulmonary sulcus tumor with activated EGFR mutation: A case report
2023 · Kai Kang, Zhixiao Jiang, et al. · Experimental and Therapeutic Medicine · 1
PDF
Role of SLC44A3-AS1 Enhancer RNA in Esophageal Cancer Prognosis
2023 · Kai Kang, Jingyi Wu, et al. · Journal of College of Physicians And Surgeons Pakistan · 1
PDF
Esophageal cancer with a double aortic arch: a case report and literature review
2022 · Kai Kang, Sheng Wang, et al. · Journal of Cardiothoracic Surgery · 1
PDF
Works count: 15
Citation count: 177
H-index: 7
I10-index: 4
Year
Topic
Type